AwesomeCapital
Search This Blog
Tuesday, August 6, 2019
Enanta Pharma EPS beats by $0.19, misses on revenue
Enanta Pharma (NASDAQ:
ENTA
): Q3 GAAP EPS of $0.33
beats by $0.19
.
Revenue of $44.4M (-22.5% Y/Y)
misses by $2.58M
.
Press Release
https://seekingalpha.com/news/3487912-enanta-pharma-eps-beats-0_19-misses-revenue
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.